O'Donnell, GB
Charles John O'Donnell, Macclesfield GB
Patent application number | Description | Published |
---|---|---|
20090105305 | Therapeutic Agents - 550 - A compound of formula I | 04-23-2009 |
20090118332 | Therapeutic Agents - 551 - A compound of formula I | 05-07-2009 |
Charles John O'Donnell, Cheshire GB
Patent application number | Description | Published |
---|---|---|
20110065706 | Therapeutic Agents 812 - A compound of formula I | 03-17-2011 |
Dara James Edward O'Donnell, Newbury GB
Patent application number | Description | Published |
---|---|---|
20140026081 | CONTROLLING WEB PAGE BEHAVIOUR - A method of controlling webpage behaviour on a web enabled device | 01-23-2014 |
Denis O'Donnell, Culmore GB
Patent application number | Description | Published |
---|---|---|
20150187373 | Method for Fabricating a Magnetic Assembly Having Side Shields - Methods for fabricating a shield structure for a pole tip of a write element for magnetic recording are disclosed. In illustrated embodiments disclosed, a side shield deposition is etched below a front edge surface of the pole tip and one or more depositions are deposited on the etched side shield deposition to form a side shield structure having an extended gap region to enhance performance of the write element. In illustrated embodiments, multiple gap depositions are deposited to form the extended gap region and side shield structure. One or both of the multiple gap depositions are etched to remove outer portions of the deposition prior to depositing the front shield structure. | 07-02-2015 |
Edward Michael O'Donnell, Maidenhead GB
Patent application number | Description | Published |
---|---|---|
20120325095 | Griddle Pan - A griddle pan for domestic use, having a base, a plurality of ridges extending upwardly from the base, and gulleys between successive ridges. The pan includes a plurality of barriers, each barrier being arrangable between successive ridges, at a height at or lower than the height of successive ridges. The barriers allow liquid to flow from tops of ridges towards the gulleys, and the barriers being arrangable to prevent at least some liquid from spitting from the gulley away through the space between the tops of successive ridges and away from the pan. | 12-27-2012 |
James O'Donnell, Worcestershire GB
Patent application number | Description | Published |
---|---|---|
20150318812 | ELECTRIC MACHINE - An electric machine has a primary mechanical output or input, a plurality of electric sub-machine rotors each having an output or input shaft, a plurality of electric sub-machine stator magnets proximate the rotors, a drive train connecting each of the output or input shafts of the plurality of electric sub-machine rotors to simultaneously drive, or be driven by, the primary output shaft. Each sub-machine is selectively engaged or disengage depending on machine power. | 11-05-2015 |
John O'Donnell, Strathaven GB
Patent application number | Description | Published |
---|---|---|
20100115871 | MOUNTING BRACKET AND METHOD FOR MOUNTING CLADDING PANELS TO A STRUCTURE - A mounting bracket is provided for mounting a cladding panel to a structure. The mounting bracket comprises a body ( | 05-13-2010 |
John Patrick O'Donnell, Manchester GB
Patent application number | Description | Published |
---|---|---|
20110014439 | Ink, Process and Use - A process for printing an image on a substrate comprising applying to the substrate by means of an ink jet printer an ink comprising the components: | 01-20-2011 |
20110169900 | Process, Dispersions and Use - A process for preparing an encapsulated pigment dispersion suitable for use in an ink jet printing ink comprising the following steps in the order I) followed by II): | 07-14-2011 |
20110175972 | Process, Dispersions and Use - A process for preparing an aqueous pigment dispersion suitable for use in an ink jet printing ink comprising the following steps in the order I) followed by II): | 07-21-2011 |
20150132545 | PROCESS FOR PREPARING AN ENCAPSULATED PARTICULATE SOLID - A process for preparing an encapsulated particulate solid using an epoxy functional cross-linking agent and a carboxylic acid functional dispersant wherein the cross-linking agent has one or more oligomeric dispersing group and/or the dispersant has an acid value of at least 125 mg KOH/g. The resultant solids are useful in, for example, ink jet printing inks. | 05-14-2015 |
20150240095 | Process, Dispersions and Use - A process for preparing an encapsulated pigment dispersion suitable for use in an ink jet printing ink comprising the following steps in the order I) followed by II): | 08-27-2015 |
John Patrick O'Donnell, Blackley GB
Patent application number | Description | Published |
---|---|---|
20120321863 | Process for preparing encapsulated solid particles - A process for preparing a dispersion of encapsulated solid particles in a liquid medium comprising: | 12-20-2012 |
Jude O'Donnell, Galbally, Dungannon GB
Patent application number | Description | Published |
---|---|---|
20160002732 | MOLECULAR DIAGNOSTIC TEST FOR CANCER - Methods and compositions are provided for the identification of a molecular diagnostic test for cancer. The test identifies cancer subtypes that have an up-regulation or a down-regulation in biomarker expression related to angiogenesis and vascular development. The present invention can be used to determine whether patients with cancer are clinically responsive or non-responsive to a therapeutic regimen prior to administration of any anti-angiogenic agent. This test may be used in different cancer types and with different drugs that directly or indirectly affect angiogenesis or angiogenesis signalling. In addition, the present invention may be used as a prognostic indicator for certain cancer types. In particular, the present invention is directed to the use of certain combinations of predictive markers, wherein the expression of the predictive markers correlates with responsiveness or non-responsiveness to a therapeutic regimen. | 01-07-2016 |
Jude O'Donnell, Galbally GB
Patent application number | Description | Published |
---|---|---|
20140031260 | Molecular Diagnostic Test for Cancer - Methods and compositions are provided for the identification of a molecular diagnostic test for cancer. The test defines a novel DNA damage repair deficient molecular subtype and enables classification of a patient within this subtype. The present invention can be used to determine whether patients with cancer are clinically responsive or non-responsive to a therapeutic regimen prior to administration of any chemotherapy. This test may be used in different cancer types and with different drugs that directly or indirectly affect DNA damage or repair, such as many of the standard cytotoxic chemotherapeutic drugs currently in use. In particular, the present invention is directed to the use of certain combinations of predictive markers, wherein the expression of the predictive markers correlates with responsiveness or non-responsiveness to a therapeutic regimen. | 01-30-2014 |
20140051591 | MOLECULAR DIAGNOSTIC TEST FOR CANCER - Methods and compositions are provided for the identification of a molecular diagnostic test for cancer. The test defines a novel DNA damage repair deficient molecular subtype and enables classification of a patient within this subtype. The present invention can be used to determine whether patients with cancer are clinically responsive or non-responsive to a therapeutic regimen prior to administration of any chemotherapy. This test may be used in different cancer types and with different drugs that directly or indirectly affect DNA damage or repair, such as many of the standard cytotoxic chemotherapeutic drugs currently in use. In particular, the present invention is directed to the use of certain combinations of predictive markers, wherein the expression of the predictive markers correlates with responsiveness or non-responsiveness to a therapeutic regimen. | 02-20-2014 |
20140342924 | Molecular Diagnostic Test for Cancer - Methods and compositions are provided for the identification of a molecular diagnostic test for cancer. The test identifies cancer subtypes that are responsive to anti-angiogenesis therapeutics and enables classification of a patient within this subtype. The present invention can be used to determine whether patients with cancer are clinically responsive or non-responsive to a therapeutic regimen prior to administration of any anti-angiogenic agent. This test may be used in different cancer types and with different drugs that directly or indirectly affect angiogenesis or angiogenesis signalling. In addition, the present invention may be used as a prognostic indicator for certain cancer types. In particular, the present invention is directed to the use of certain combinations of predictive markers, wherein the expression of the predictive markers correlates with responsiveness or non-responsiveness to a therapeutic regimen. | 11-20-2014 |
20160060705 | MOLECULAR DIAGNOSTIC TEST FOR CANCER - Methods and compositions are provided for the identification of a molecular diagnostic test for cancer. The test defines a novel DNA damage repair deficient molecular subtype and enables classification of a patient within this subtype. The present invention can be used to determine whether patients with cancer are clinically responsive or non-responsive to a therapeutic regimen prior to administration of any chemotherapy. This test may be used in different cancer types and with different drugs that directly or indirectly affect DNA damage or repair, such as many of the standard cytotoxic chemotherapeutic drugs currently in use. In particular, the present invention is directed to the use of certain combinations of predictive markers, wherein the expression of the predictive markers correlates with responsiveness or non-responsiveness to a therapeutic regimen. | 03-03-2016 |
Martin O'Donnell, Solihull GB
Patent application number | Description | Published |
---|---|---|
20090159136 | VALVE ASSEMBLY - A valve assembly comprising a support body ( | 06-25-2009 |
Matthew O'Donnell, Leighton Buzzard GB
Patent application number | Description | Published |
---|---|---|
20140056954 | Multicomponent Glasses For Use In Personal Care Products - The present invention relates to multicomponent glasses and their use in powdered form as an additive in personal care products such as toothpastes. | 02-27-2014 |
Matthew O'Donnell, London GB
Patent application number | Description | Published |
---|---|---|
20110045052 | Bioactive Glass Coatings - The present invention relates to bioactive glass coatings. In particular, the present invention relates to bioactive glass coatings for Ti6Al4V alloys and chrome cobalt alloys, wherein the thermal expansion coefficient of the glass coating is matched to that of the alloy. Such coatings have a particular application in the field of medical prosthetics. The bioactive glass comprises (in mol %) 35-53 SiO2; 2-11 Na20; at least 2% of each of CaO, MgO and K20; 0-15 ZnO; 0-2 B202 and 0-9 P205. | 02-24-2011 |
Michael Edward O'Donnell, Abingdon GB
Patent application number | Description | Published |
---|---|---|
20130095193 | COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE - The present invention relates to compounds useful as inhibitors of ATR protein kinase. The invention also relates to pharmaceutically acceptable compositions comprising the compounds of this invention; methods of treating of various diseases, disorders, and conditions using the compounds of this invention; processes for preparing the compounds of this invention; intermediates for the preparation of the compounds of this invention; and methods of using the compounds in in vitro applications, such as the study of kinases in biological and pathological phenomena; the study of intracellular signal transduction pathways mediated by such kinases; and the comparative evaluation of new kinase inhibitors. | 04-18-2013 |
20130115313 | Compounds Useful as Inhibitors of ATR Kinase - The present invention relates to compounds useful as inhibitors of ATR protein kinase. The invention also relates to pharmaceutically acceptable compositions comprising the compounds of this invention; methods of treating of various diseases, disorders, and conditions using the compounds of this invention; processes for preparing the compounds of this invention; intermediates for the preparation of the compounds of this invention; and methods of using the compounds in in vitro applications, such as the study of kinases in biological and pathological phenomena; the study of intracellular signal transduction pathways mediated by such kinases; and the comparative evaluation of new kinase inhibitors. | 05-09-2013 |
20150099875 | METHODS OF REGIOSELECTIVE SYNTHESIS OF 2,4-DISUBSTITUTED PYRIMIDINES - The present invention relates to the novel regioselective syntheses of 2,4-disubstituted pyrimidines through sequential nucleophilic aromatic substitutions. | 04-09-2015 |
Pete O'Donnell, Leamington Spa GB
Patent application number | Description | Published |
---|---|---|
20160107088 | MUSIC BASED VIDEO GAME WITH USER-GENERATED CONTENT - A video game includes user generated content. The video game may be a music-based video game. Users may determine content to be played, and a server may provide the content to game devices for play, for example at predefined times, and/or to predetermined game players. | 04-21-2016 |
20160107089 | MUSIC BASED VIDEO GAME WITH COMPONENTS - A video game includes a plurality of components providing for opportunities for increased social interaction of users playing the video game. The video game may be a music-based video game, and a server may provide content of the video game to game devices for play at predefined times. | 04-21-2016 |
Ray O'Donnell, North Stainley North Yorkshire GB
Patent application number | Description | Published |
---|---|---|
20080281080 | Purification of Recombinant Human Factor XIII - The present invention provides improved methods for the purification of factor XIII. In particular, the methods provide compositions containing 5% or less contaminating proteins. In particular embodiments of the present invention the methods provide purified factor XIII compositions comprising less than 1% activated factor XIII, less than 2% protein aggregates, and/or less than 5% charge isomers of factor XIII. The methods do not require the use a precipitation or crystallization step common to prior methods of isolating factor XIII. Instead, the method uses immobilized metal affinity chromatography to remove various contaminants common to recombinant expression of factor XIII. Further, a combination of various chromatography methods including ion exchange chromatography, hydrophobic affinity chromatography, and immobilized metal affinity chromatography comprise a simple and less expensive method to produce a pharmaceutical grade factor XIII product at high yield. | 11-13-2008 |
Valerie O'Donnell, Penarth GB
Patent application number | Description | Published |
---|---|---|
20100331268 | Nitrated Lipids and Methods of Making and Using Thereof - Described herein are nitrated lipids and methods of making and using the nitrated lipids. | 12-30-2010 |
20130210917 | Nitrated Lipids and Methods of Making and Using Thereof - Described herein are nitrated lipids and methods of making and using the nitrated lipids. | 08-15-2013 |
20150246059 | NITRATED LIPIDS AND METHODS OF MAKING AND USING THEREOF - Described herein are nitrated lipids and methods of making and using the nitrated lipids. | 09-03-2015 |